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1. Introduction
   Atherosclerosis is a disease of blood vessels and known 
colloquially as ‘hardening of the arteries’. It is characterized 
by the accumulation of fatty substance, cholesterol, cellular 
waste products, calcium and other substances in the inner 
lining of an artery. Major complications of atherosclerosis 
include angina pectoris, myocardial infarction and stroke, 
which are recognized as leading causes of morbidity 
and mortality in Western countries. The World Health 
Organization predicted that heart diseases and stroke are 
becoming more deadly, with a projected combined death 
toll of 24 million by 2030[1]. It is worth noting that the 
prevention of formation of atheromatous lesions has become 
one of the most important targets in the prophylaxis and 
therapy of cardiocirculatory disorders with atherothrombotic 
complications. The use of various drugs in treating such 
alignments is associated with high risk of myosistis, angio-
oedema, myoglobinuria, acute renal failure etc[2]. Because 
of the shortcomings of the available drugs, attempts are 
underway to explore natural sources with antiatherosclerotic 
activity. 
   A dietary product bottle gourd, Lagenaria siceraria (L. 
siceraria) (Molina) Standley, family Cucurbitaceae, is a 
climbing vine and possesses various medicinal properties. 
L. siceraria is official in Ayurvedic Pharmacopoeia of India. 
The fruits of L. siceraria are cooked as a vegetable part of 
food in India and many other countries. The fruits of L. 
siceraria are traditionally used as a nutritive agent having 
cardioprotective, cardiotonic, general tonic, diuretic, 
aphrodisiac, antidote to certain poisons and scorpion stings, 
alternative purgative and cooling effects. It cures pain, 
ulcers, and fever and also used for jaundice, pectoral-
cough, asthma and other bronchial disorders[3,4]. The 
edible portion of fruits is fair source of ascorbic acid, beta 
carotene and good source of vitamin B complex, pectin 
dietary soluble fibers and contains highest source of choline 
level-anisotropic factor[4]. Modern phytochemical screening 
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methods showed the presence of triterpenoid cucurbitacins 
B, D, G, H and 22-deoxycucurbitacin “the bitter principle 
of cucurbitaceae”, fucosterol, campesterol[5,6], cytotoxic 
triterpenoids D:C-Friedooleanane[7], bryonolic acid an 
antiallergic compound[8]and flavone C-glycosides[9]. 
Lagenin, a novel ribosome inactivating protein has been 
isolated from the lyophilized water extract of seeds which 
is known to possess immunosuppressive, antitumour, 
antiviral, antiproliferative and anti-HIV activities[10]. A 
water soluble cytotoxic polysaccharide, isolated from fruits 
of L. siceraria is composed of methyl-α-d-galactuoronate, 
3-O-acetyle methyl-α-d-galacuoronate and β-d-
galactose[11]. Pharmacological properties of the herb 
include hepatoprotective, antioxidant, antihyperglycemic, 
immunomodulatory, antihyperlipidemic, cardiotonic, 
diuretic, antibacterial, analgesic, anti-inflammatory, 
cytotoxic, cardioprotective, anti ulcer, anticestodal, 
urolithiatic, antihypertensive, fibrinolytic, antiplatelet, 
antithrombotic and antihelminthic activity[12,15] .
   Previous studies indicated that various extracts of fruits of 
L. siceraria and its isolated compounds inhibited the total 
cholesterol, triglycerides, low-density lipoproteins level 
and significantly increased the high density lipoproteins 
level in normal and hypercholesterolemic rats showing 
antihyperlipidemic and hypolipidemic effect[16,17]. However, 
the direct measurement of its ameliorating potential on the 
atheromatous lesions has not been investigated yet. The 
present study aims to investigate the antiatherosclerotic 
potential of a commonly edible vegetable L. siceraria, by 
investigating its protective effect on atheromatous lesions in 
hypercholesterolemic rats. Additionally, an attempt has been 
made to reveal out the possible mechanism of lipid lowering 
mechanism of ethanolic extract of fruits of L. siceraria by 
measuring HMG-CoA reductase enzyme and lipoprotein 
lipase enzymes levels in hyperlipidemic rats.
2. Materials and methods 
2.1. Chemicals and instruments 
   Olive oil (Figaro, Spain) was purchased from the local 
pharmacy, Indore, India.  Cholecalciferol (60 000 IU), Cadila 
Pharmaceuticals, Ankleshwar, India; Cholesterol, Alpha 
Chemika, Mumbai, India and Atorvastatin, Ranbaxy Lab. 
Sirmour, India, were procured. Total cholesterol, triglyceride 
and high density lipoprotein cholesterol diagnostic kids were 
purchased from Reckon Diagnostic Kits, Vadodara, India. 
All the other chemicals and reagents used were of analytical 
grade and obtained from Sigma-Aldrich Co., Mumbai, India. 
Spectra were determined on Shimadzu UV-1601 (Shimadzu, 
Kyoto, Japan) spectrophotometer over a scanning range of 
200-800 nm. Colorimetric estimations were made using 
Spectronic-20 colorimeter (Lab Sales Corporation, India).  
2.2. Plant material 
   Fresh fruits of L. siceraria were purchased in August 2009, 
from the local market of Indore city. Authentication of the 
plant on basis of pharmacognostic study and organoleptic 
characteristics was done by Mr T. Chakraborty, Scientist ‘D’ 
for Joint Director, Botanical Survey of India, Pune, India. A 
voucher specimen (MITRALAS6) has been deposited in our 
college herbarium for future reference. 
2.3. Preparation of L. siceraria ethanolic extract
   Fruits of L. siceraria were sliced and shade dried. After 
complete removal of moisture, fruits were pulverized to 
obtain coarse powder and defatted by maceration with 
petroleum ether for 48 h. The defatted material was then 
subjected to Soxhlet extraction with 95% ethanol and 
concentrated in vacuo to obtain L. siceraria ethanolic extract 
(LSEE). LSEE was stored in tightly closed container and kept 
in refrigerator. The amount of extract calculated as per the 
dose was dissolved in distilled water for oral administration 
to experimental animals. Preliminary phytochemical 
screening of LSEE was done according to standard 
procedures[18] .
2.4. Animals
   Wistar rats of either sex weighing (300 依 15) g were 
procured from the animal house of College of Pharmacy, IPS 
Academy, Indore, India. Animals were placed randomly in 
polypropylene cages under standard conditions of humidity 
(55 依 5)%, temperature (25 依 2) 曟 and 12 h/12 h, light/dark 
cycles and free access standard pellet diet (Hindustan 
Lever Ltd., Mumbai, India) and filtered water ad libitum. 
Experiments were conducted in accordance with the 
internationally accepted principles for laboratory animal use 
and care as per the US guidelines (NIH publication #85-23, 
revised in 1985). Experiments were conducted after obtaining 
the approval from Institutional Animal Ethics Committee 
constituted as per Committee for the Purpose of Control and 
Supervision of Experiments on Animals. 
2.5. Acute toxicity studies
   Acute toxicity studies were performed as per OECD-423 
guidelines on randomly selected rats of either sex (n=6). 
LSEE (5 mg/kg) was administered orally after overnight 
fasting. Since mortality was not observed, the procedure was 
repeated with higher doses viz. 50, 300 and 2 000 mg/kg body 
weight[19]. The animals were observed for toxic symptoms 
and mortality for 72 h.
2.6. Antiatherosclerotic activity in hypercholesterolemic rats
   Albino wistar rats of either sex weighing (300 依 15) g were 
divided into five different groups of six rats each. For the 
whole experimental period that is for five days, animals of 
first group received normal pellet diet (normal group), while 
second group received atherogenic diet (control group), 
third, fourth and fifth group in addition with atherogenic 
diet received 200, 400 mg/kg, p.o. of LSEE and atorvastatin 
(10 mg/kg, p.o., suspended in 1% gum acacia) respectively. 
Atherogenic diet contained per kg body weight and per day 
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1.5 mL of an olive oil solution, containing per ml: vitamin D3 
(cholecalciferol) 320 000 IU and cholesterol 40 mg[20-22]. All 
the animals received commercial pellet diet and water ad 
libitum for the period of study.
   At the end of study period that is on sixth day the overnight 
fasted rats were sacrificed under ether anesthesia. Blood 
was collected directly from the heart and stored at -20 曟 
for biochemical estimations. Liver was removed and stored 
in formaldehyde solution to determine HMG-CoA reductase 
activity. The aorta extending from the base of the heart to 
the iliac bifurcation was removed. The aorta was sliced to 
make strips of 2 × 1 cm and plaque formation on the internal 
surface was photographed by using a Sony digital still 
camera (DSC-W180). Planimetry studies of cross sections of 
aorta were made with the help of camera lucida drawings at 
20×. The level of plaque formation on the internal aorta was 
calculated by using the equation: (area of plaque formation 
on internal aorta/total area) × 100. Grading of atherosclerosis 
was done on 0-4 scale as described by Duff and Mcmillan, 
1949. The total number of lesions in each aorta was counted 
as follows. The total number of lesions in each group was 
then pooled and percentage of each grade of lesion in each 
group was calculated. Grade Zero: Gross inner surface of 
aorta was smooth and shining. Grade 1: Gross-small, pin 
head size elevations on intimal surface which could be easily 
separated from intimal surface. Grade 2: Fibrous plaques 
one or more often elongated in shape and their size varied 
from pin head to few millimeters elevated from surface and 
could not be detached easily. Grade 3: Irregular map like 
patches of 10-15 mm in size with yellow color. Grade 4: Big 
whitish yellow areas with marked deposition of calcium. 
   For biochemical estimations, serum samples were 
analyzed for total cholesterol (TC), triglyceride (TG) and high 
density lipoprotein cholesterol (HDL-c) using diagnostic 
kids (Reckon Diagnostic Kits, Vadodara, India). Low density 
lipoprotein cholesterol (LDL-c) and very low density 
lipoprotein cholesterol (VLDL-c) were determined using 
Fridwald’s formula. Atherogenic Index was also calculated 
to access the atherogenic risk[23].
   Friedewald’s Formula: LDL = TC - [VLDL-c + HDL-c], 
where VLDL-c = TG/5.
   Atherogenic Index (AI) = TG/HDL-c
For histopathological studies, aorta specimens were fixed 
in 10% buffered formaldehyde solution, sectioned and 
embedded in paraffin wax using conventional techniques. 
The aortas were cut transversely at the arch and mid thoracic 
level. They were fixed in bouin’s fluid for 24 h and process 
for routine histopathological examination by passing through 
graded alcohols. Tissue slide sections of 6-8 毺m thickness 
were taken with the help of microtome, transferred on glass 
slides and stained with haematoxylin and eosin. The stained 
sections were examined under Olympus photomicroscope 
(Magnus MLX-B series, India Pvt. Ltd.) and photographed 
(40×). 
2.7. Plasma lipoprotein lipase (LPL) assay
   Lipoprotein lipase was assayed in plasma by the method 
of Korn (1962)[24]. The amount of glycerol liberated was 
determined calorimetrically.
   Incubation: The incubation mixture consisted of 0.4 mL 
of 20% albumin (pH 8.5), 0.1 mL ammonium sulfate, 0.1 mL 
substrate, 0.1 mL enzyme source and sufficient water to 
make up a final volume of 1.0 mL. The plasma collected by 
centrifugation of blood from different group animals at 3 000 
rpm for 5 min was used as the enzyme source. The human 
lipoid serum (TG < 400 mg/dL) was used as the substrate. 
Albumin was added to the incubation tube to bind the 
un-esterified fatty acids which otherwise will inhibit the 
reaction. Ammonium ions were also added to provide the 
necessary activating cation. The mixture was incubated 
at 37 曟 for 1 h and the aliquots were taken into tubes 
containing 0.1 mL of 1 N H2SO4 at intervals of 0, 30, 60, 90 
min. The samples were transferred directly into a 10 mL 
conical tip centrifuge tube containing 0.1 mL of 1N H2SO4.
   Glycerol determination: Sodium periodate (0.1 mL, 
0.05 M) was added to the centrifuge tube, mixed well and 
allowed to stand at room temperature for 5 min. Then 0.1 
mL sodium arsenate (0.05 M) was added, mixed well and 
again allowed to stand at room temperature for 10 min. This 
was followed by the addition of 9.0 mL chromotropic acid, 
mixed by inversion (covering the top of the tube by paraffin) 
and placed in a boiling water bath for 30 min, cooled and 
the volume adjusted to 10 mL with water. The optical 
density was read at 570 nm. The assay was standardized 
with glycerol solution of known molarity and the glycerol 
liberated was calculated. The activity of lipoprotein lipase 
is expressed as mg of glycerol liberated/h/dL plasma or mg 
of glycerol liberated/h/mg protein. The same procedure was 
repeated using plasma of animals treated with LSEE (200 and 
400 mg/kg) and atorvastatin (10 mg/kg) for a period of 10 min. 
The glycerol liberated was calculated and compared with 
normal untreated group[24].
2.8. Hepatic hydroxy-methyl glutaryl-coenzyme a reductase 
(HMG-CoA reductase) assay
   The ratio between HMG-CoA and mevalonate in tissues 
was taken as an index of the activity of HMG-CoA reductase 
as described by Rao et al[25]. Equal volumes of fresh 10% 
tissue homogenate and dilute perchloric acid were mixed, 
kept for 5 min and centrifuged at 2 000 × g for 10 min. 
To 1.0 mL of filtrate, 0.5 mL of freshly prepared alkaline 
hydroxylamine reagent was added, mixed and after 5 min 
1.5 mL of FeCl3 was added and shaken well. Readings were 
taken after 10 min at 540 nm against a similarly treated 
saline-arsenate blank. The ratio (absorbance of HMG-CoA/
absorbance of mevalonate) was determined and is taken as 
an index of the activity of HMG-CoA reductase required 
to convert HMG-CoA to mevalonate. Lower ratio indicates 
higher enzyme activity and vice-versa. The same procedure 
was repeated using tissue homogenates of animals treated 
with LSEE (200 and 400 mg/kg) and atorvastatin (10 mg/kg)
[25].
2.9. Statistical analysis
   Data was expressed as the mean 依 standard error of mean 
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(S.E.M) and statistical analysis was carried out employing 
‘unpaired two-tailed student t test, Welch corrected’ and 
one way analysis of variance (ANOVA) followed by ‘Dunnett’ 
multiple comparisons test of P<0.05 significance level using 
“Graphpad Instat” version 3.00 for windows 95, Graphpad 
software, San Diego, California, USA. 
3. Results 
   The percentage yield of LSEE was found out to be 28.8%. 
Preliminary phytochemical screening of LSEE revealed 
the presence of polyphenolics as flavonoids (C-flavone 
glycosides, ellagitannins), triterpenoids (saponins, 
cucurbitacins), sterols, soluble diatery fibres, insoluble 
cellulose fibres, pectin, cardiotonic aglycones, proteins and 
carbohydrates. 
   No mortality occurred in the group of rats receiving up to 
2 000 mg/kg p.o. LSEE (LD50 >2 000 mg/kg). Hence, in this 
study 1/10th and 1/5th of the dose that is, 200 and 400 mg/
kg has been used. L. siceraria is being used as a vegetable 
since ancient time, fresh juice obtained from 200-300 g 
L. siceraria fruit is recommended in ‘Dudhi Therapy’[26], 
indicating its well established safety.
   The serum levels of cholesterol and triglycerides and 
atherogenic index were increased by 4.0, 5.6 and 12.60 
fold respectively, five days after the administration of 
atherogenic diet in control group animals. LSEE (200 and 400 
mg/kg, p.o.) administration effectively prevented this rise in 
cholesterol and triglycerides. The effect of LSEE is almost 
comparable to that of atorvastatin. Table 1 shows the values 
of serum lipid profile in normal, cholesterol fed (control) and 
various treatment groups. Serum total cholesterol, LDL-c, 
VLDL-c and triglycerides levels increased and HDL-c level 
decreased significantly (P<0.01) after 5 d of high atherogenic 
diet feeding. Concurrent administration of LSEE (200 and 
400 mg/kg, p.o.) with atherogenic diet caused a significant 
decrease (P<0.01) in the levels of serum total cholesterol, 
LDL-c, VLDL-c and triglycerides and significant increase 
(P<0.01) in HDL-c when compared with cholesterol fed 
control rats. The atherogenic index was also declined 
significantly as compared to cholesterol fed control rats.
   The aorta of atherogenic diet fed rats showed the presence 
of large atherogenic plaque protruding in the lumen 
covering 28.90% area. Administration of LSEE at dose of 
200 and 400 mg/kg caused a significant amelioration in 
the atherosclerotic lesions as evidenced by significant 
(P<0.01) reduction in the plaque size up to 13.61% and 
9.37%. Furthermore, atorvastatin (10 mg/kg) decreased the 
atherogenic plaque up to 2.82% (Table 2). 
   The liver HMG-CoA reductase and lipoprotein lipase 
enzymes activity are shown in Figure 1. LSEE at dose of 200 
mg/kg did not exhibit significant change in hepatic HMG-
CoA reductase activity as compared with control group. 
However, the extract at dose of 400 mg/kg and atorvastatin 
(10 mg/kg) showed significant increase (P<0.05 and P<0.01 
respectively) in the ratio of HMG-CoA to mevalonate, 
indicating decreased HMG-CoA reductase enzyme activity. 
For the measurement of lipoprotein lipase activity, LSEE 
treated animals for a period of 10 min showed increased 
production of glycerol as an index of the greater release. 
The glycerol liberated in the extract treated and atorvastatin 
treated animals was found to be increased significantly 
(P<0.01) as compared with control group.
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Figure 1. Modulatory effect of ethanolic extract of fruits of L. 
siceraria on plasma lipoprotein lipase releasing activity and HMG-
CoA reductase activity in hypercholesterolemic rats.
AD: Atherogenic diet, it contained (kg-1, day-1) 1.5 mL of olive oil 
solution containing per ml: vitamin D3 (cholecalciferol) 320 000 IU 
and cholesterol 40 mg. LSEE: L. siceraria ethanolic extract, LSEE: L. 
siceraria ethanolic extract, Ator: Atorvastatin.
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   The lesions in the rats receiving atherogenic diet only, were 
Table 1
Effects of ethanolic extract of fruits of L. siceraria and atorvastatin on serum biochemical parameters in hypercholesterolemic rats.
Treatment
Biochemical parameters (mg/dL) AI
TC TG HDL-c LDL-c VLDL-c
Normal diet (normal group)  74.37 依 4.89  61.83 依 3.91 32.59 依 2.28 29.42 依 1.83 12.36 依 0.78   1.89
Atherogenic diet (control group)   302.57 依 18.93a   345.91 依 12.40a  14.51 依 1.36a  218.88 依 15.09a  69.18 依 2.48a 23.83
Atherogenic diet + LSEE (200 mg/kg) 138.52 依 6.98c 189.17 依 5.86c  16.92 依 2.96c  83.77 依 2.85c  37.83 依 1.17c 11.18
Atherogenic diet + LSEE (400 mg/kg) 101.86 依 4.22c 125.44 依 4.73c  22.91 依 1.76b  53.87 依 1.52c  25.08 依 0.94c   5.47
Atherogenic diet + Atorvastatin (10 mg/kg)   89.04 依 3.88c 117.23 依 4.29c  26.02 依 1.95c  39.58 依 1.08c  23.44 依 0.85c   4.50
Results are expressed as mean 依 S.E.M.; n=6 in each group. Data of normal group were compared with their respective control using ‘unpaired t 
test, Welch corrected’ (significance: aP<0.001). The data of various treatment groups were compared with their respective control using one way 
ANOVA followed by ‘Dunnett test’ (significance: bP<0.05, cP<0.01, nsP>0.05). 
Atherogenic diet: It contained (kg-1, day-1) 1.5 mL of olive oil solution containing per ml: vitamin D3 (cholecalciferol) 320 000 IU and cholesterol 
40 mg. LSEE: L. siceraria ethanolic extract, TC: total cholesterol, TG: triglyceride, HDL-c: high density lipoprotein cholesterol, LDL-c: low 
density lipoprotein cholesterol, VLDL-c: very low density lipoprotein cholesterol, AI: atherogenic index.
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generally calcified and exhibited grade 4 atherosclerosis. 
Whereas the other groups treated additionally with LSEE 
(200 and 400 mg/kg) and atorvastatin (10 mg/kg) exhibited 
few lesions and largely atherosclerosis of grade 1 and 2. No 
calcified lesions were seen in these treated groups (Figure 2). 
4. Discussion 
   Recently there is an increased research in herbal 
medicines after observations that they are effective for 
conditions to which they have traditionally been applied. 
Herbal medicines are fast emerging as an alternative 
treatment to available synthetic drugs for treatment of 
various diseases possibly due to lower cost, availability, 
fewer adverse effects and perceive effectiveness. The 
present investigation has explored the use of one such plant 
L. siceraria, abundantly found in the Indian continent, for 
antiatherosclerotic activity. 
   Atherogenicity with subsequent cardiovascular 
manifestations is one of the important causes of high 
mortality and morbidity. It is well documented that elevated 
lipid levels and their oxidative modification appears to have 
an important role in initiation and progression of atherogenic 
changes in aorta. Cholesterol feeding in rats causes a 
significant increase in the circulating total cholesterol, 
LDL-c, VLDL-c, triglycerides and decrease in HDL-c levels 
indicating increased risk of atherosclerosis and coronary 
heart disease[27]. Previous studies indicate that various 
extracts of fruits of L. siceraria and their isolated compounds 
exhibit significant effects in lowering total cholesterol, 
triglyceride and LDL-c along with increase in HDL-c 
reporting marked antihyperlipidemic and hypolipidemic 
activity[16,17]. The effects of LSEE on serum TNF-毩 
indicating lowering effect on fat amassment in obese rats has 
also been investigated[28]. Total cholesterol content of the 
aorta is a good indirect measure of atherosclerotic severity 
in cholesterol fed rats[29]. However, the direct measurement 
of its ameliorating potential on the atheromatous lesions has 
not been investigated yet. Hence, in this study an attempt 
has been made to access the antiatherosclerotic potential of 
L. siceraria by calculating percentage plaque area in aorta 
and grade of atheromatous lesions in hypercholesterolemic 
rats. 
   The search for a laboratory model to study potential 
an t i a the r o sc l e r o t i c  c ompounds  ha s  been  we l l 
documented[30]. Generally rabbit models are potential 
targets to study antihyperlipidemic and hypolipidemic 
Table 2
Effects of ethanolic extract of fruits of L. siceraria and atorvastatin on atheromatous lesions in hypercholesterolemic rats.
Treatment
Atherosclerotic lesions (Percentage of grade) % plaque formation
Grade 1 Grade 2 Grade 3 Grade 4
Atherogenic diet   9.09 依 0.40 12.12 依 0.37 24.24 依 0.24  54.54 依 0.24 28.90 依 1.76
Atherogenic diet+LSEE (200 mg/kg) 54.28 依 0.58 34.28 依 0.50 11.42 依 0.20    0.00 依 0.00  13.61 依 0.67a
Atherogenic diet+LSEE (400 mg/kg) 52.38 依 0.37 33.33 依 0.24 14.28 依 0.24    0.00 依 0.00    9.37 依 1.40a
Atherogenic diet+Atorvastatin (10 mg/kg) 64.20 依 0.37 21.42 依 0.24 14.28 依 0.24    0.00 依 0.00    2.82 依 0.37a
Results are expressed as mean 依 S.E.M.; n=6 in each group. Data was analyzed by one way ANOVA followed by ‘Dunnett test’. Significance: 
aP<0.01 as compared with atherogenic diet group.
Atherogenic diet: It contained (kg-1, day-1) 1.5 mL of olive oil solution containing per ml: vitamin D3 (cholecalciferol) 320 000 IU and cholesterol 
40 mg. LSEE: L. siceraria ethanolic extract.
Figure 2. Histopathology of cross sections of aorta from atherogenic diet treated (A), atherogenic diet + LSEE (200 mg/kg) treated (B), 
atherogenic diet + LSEE (400 mg/kg) treated (C) and atherogenic diet + atorvastatin (10 mg/kg) treated (D) rats. 
Atherosclerotic lesions were detected as areas of light staining in the wall of the aortic sinus (arrows) (40×). Atherogenic diet: It contained 
(Kg-1, day-1) 1.5 mL of olive oil solution containing per ml: vitamin D3 (cholecalciferol) 320 000 IU and cholesterol 40 mg. LSEE: L. siceraria 
ethanolic extract.
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studies in vivo. The rat has received little attention and 
is generally considered to be resistant to the induction of 
atheromatous lesions and required to more than one month 
to induce hyperlipidemia. However, following the reports 
of Altman (1972)[21] and Testa et al[31]a short-term induction 
of atherosclerosis in the rat seemed possible using large 
doses of vitamin D2 and cholesterol. Parke et al[22] have 
also undertaken a series of experiments to investigate the 
methodology to induce hyperlipidemia in rats in a period 
of five days and succeeded. Similarly, Lata et al[20]carried 
out a study to compare three herbal extracts for their 
beneficial effects against hyperlipidemia in rats in five 
days. In our study, successful attempts are made to induce 
hypercholesterolemia in five days in rats using cholesterol, 
cholecalciferol and olive oil and the results are found 
consistent with previous studies.  
   Various agents which affect hyperlipidemia are still not 
used for prevention of atherosclerosis because of their 
potential toxicity and intolerance. L. siceraria is reported to 
lower serum lipid levels and is well tolerated as it forms the 
constituent of customary Indian diet. In present study, LSEE 
(200 and 400 mg/kg) administration effectively prevented 
rise in the levels of serum total cholesterol, LDL-c, VLDL-c 
and triglycerides and significant increase in HDL-c when 
compared with cholesterol fed control rats, consistent with 
what have been reported previously[16,17,28].
   Administration of LSEE (200 and 400 mg/kg) caused a 
significant amelioration in the atherosclerotic lesions 
(28.90%) as evidenced by significant reduction in the 
plaque size up to 13.61 and 9.37%. It has been reported 
that changes in membrane cholesterol content affects its 
fluidity, permeability to ions, activities of membrane bound 
enzymes and increased degradation of phospholipids[32]. 
Hypercholesterolemia has been reported to cause endothelial 
cell dysfunction, as evidenced by an increase in endothelial 
cell turnover in cholesterol fed rabbits and swine and 
increased permeability of the endothelium in cholesterol 
fed rabbits[33]. In our study, aortic cross sections from rats 
fed with atherogenic diet exhibited well defied calcification, 
which is an indication of advanced complicated plaques. 
With extract treatment aortic cross sections were found to be 
normal and atherosclerosis was reversed. 
   Alteration of lipid profile is controlled by those 
enzymes that are responsible for lipid metabolism. The 
current study has demonstrated the effect of LSEE on 
HMG-CoA reductase enzyme and lipoprotein lipase 
enzymes activity for cholesterogenesis and plasma lipids 
regulation respectively revealing possible mechanism of 
antihyperlipidemic action of the extract.  In this study 
cholesterol fed rats showed a significant decrease in 
plasma lipoprotein lipase activity. Lipoprotein lipase is the 
atheroprotective enzyme expressed by parenchymal cells, 
involved in the metabolism of triglycerides rich lipoproteins. 
Elevated triglyceride rich lipoprotein levels may not only 
promote a more rapid progression of atherosclerosis but 
also lead to myocardial ischemia[32]. The lower activity 
of this enzyme indicates decreased uptake of circulating 
triglyceride rich lipoproteins. LSEE treated group showed 
a significant increase in lipoprotein lipase activity 
indicating its protective effects towards atherogenesis in 
hypercholesteroemic rats due to elevation of HDL-c. The 
HDL-c has a dual anti-atherogenic effect: it functions as 
a removal vehicle for cholesterol, transporting it away from 
areas of production to the liver where it can be excreted as 
bile salts and, in addition, it has been shown to prevent the 
oxidation of LDL-c by metal ions[34] . 
   The liver occupies a key position in cholesterol 
metabolism. Hepatocytes derive cholesterol from circulating 
lipoproteins or by de novo synthesis and use it for membrane 
synthesis, bile acid synthesis and secretion, secretion of 
free sterol into the bile, lipoprotein formation, and storage 
of excess sterol as cholesterol ester[34]. The hepatic enzyme 
HMG-CoA catalysis the rate limiting step in cholesterol 
biosynthesis in the tissues and its activity closely correlates 
with cholesterogenesis in the tissues. Regulation appears 
to involve changes in the rate of reductase synthesis, 
modulation of catalytic activity and the action of hormones. 
Defective regulation of HMG-CoA reductase has been 
demonstrated previously in hepatic tumor cells and has 
been implicated in familial hypercholesterolemia. The 
increased activity of the enzyme in the liver of rats fed with 
high fat diet corresponds with increased cholesterogenesis, 
as indicated by the higher incorporation of blood plasma 
total cholesterol and LDL-c cholesterol was observed in our 
current study. 
   The animals treated with LSEE (400 mg/kg) and atorvastatin 
(10 mg/kg) had shown decreased activity of enzyme as 
evidenced by the reduction in plasma total cholesterol and 
LDL-c. By inhibiting HMG-CoA reductase, statins reduce 
the hepatocyte cholesterol content and increase expression 
of LDL-c receptors, responsible for LDL-c cholesterol 
uptake via receptor-mediated endocytosis[35]. Additionally, a 
second mechanism of LDL-c reduction may relate to LDL-c 
and VLDL-c interactions. However, increases in HMG-
CoA reductase synthesis shortly after statin therapy restore 
cellular VLDL-c levels, and the ultimate effect of reductase 
inhibition is enhanced LDL-c receptor expression and lower 
plasma LDL-c in the setting of normal cellular cholesterol 
content[36] .
   Kaempferol and isoquercetrin flavonoids have been 
isolated from the fruits of Lagenaria siceraria [37,13]. 
Flavonoids may augment the activity of lecithin aryl 
transferase (LAT) which regulates blood lipids by 
incorporation of free cholesterol into HDL-c and transferring 
it back to VLDL-c and LDL-c which are taken back later in 
lever cells. Polyphenolic compounds also possess a variety 
of biological activities, such as reduction of plasma lipids, 
which might be due to the up-regulation of LDL receptor 
expression[38], inhibition of hepatic lipid synthesis[39] and 
lipoprotein secretion[40]. It is possible that the activity 
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in lowering lipid levels and aortic plaque formation of 
the L. siceraria fruit extract may result from the phenolic 
compounds present in the extract. 
   It has also been ascertained that parts of soluble dietary 
fibers such as pectin from the fruits of L. siceraria may have 
cholesterol lowering effect. Soluble dietary fiber contents 
are having the beneficial effect in the promotion of bile acid 
formation and their excretion in the stool or in the blockade 
of cholesterol absorption[41].
   The lipid lowering effects of the extract may be due to its 
content of plant sterols and fixed oils which are considered 
as good source of mono and poly unsaturated fatty acids and 
cardiac aglycones. The white sterol crystals or phytosterols 
from the methanol extract of L. siceraria were isolated and 
identified as a mixture of four sterols, including fucosterol, 
racemosol, stigmasterol and stigmasta-7,22-dien-3毬,
4毬-diol[42]. Plant sterol reduces intestinal absorption of 
cholesterol resulting in an increase in fecal excretion of 
neutral lipids and steroids which results in decrease of body 
lipids[43].
   Saponins and fatty oil are the major phytoconstituents 
present in fruits of L. siceraria. Bitter fruits yield 0.013% 
of a solid foam containing cucurbitacin B, D, G and 
H, mainly cucurbitacin B. These bitter principles are 
present in the fruit as aglycones[3]. The presence of large 
amount of saponins in fruits of L. siceraria may be the 
phytoconstituent responsible for lipid lowering property. 
Saponins also act as antihyperlipidemics by one of the 
following mechanisms as by binding with cholesterol in 
intestinal lumen, so that cholesterol is less readily absorbed 
or bile acids causing reductions in its extra hepatic 
circulation and increasing metabolism of cholesterol to 
sterols through their fecal secretion. Increase in bile acid 
excretions offset by enhanced synthesis from cholesterol 
in the lever consequently lowers the plasma cholesterol. 
Saponins are also reported to increase the lipoprotein lipase 
activity, which is helpful in faster removal of free fatty 
acid from circulation that causes in turn a decrease in total 
cholesterol[44,45]. Thus on the basis of results of the present 
study, it can be concluded that ethanolic extract of fruits of 
L. siceraria have a definite potential as reported for several 
traditional antihyperlipidemic drugs. Further research on 
the fractionation of extracts, isolation, purification and 
characterization of active constituents responsible for the 
lipid lowering activity and their mechanisms are in progress. 
   From these result it can be concluded that ethanolic 
extract of fruits of L. siceraria contains active components 
which decreases serum lipid profile and lowers the risk of 
atherosclerosis by lowering percentage plaque area in aorta 
and grade of atheromatous lesions in hypercholesterolemic 
rats. 
   Ethanolic extract of fruits of L. siceraria has been shown 
to induce lipoprotein lipase activity and significantly 
decreased cholesterogenesis in liver by reducing HMG-CoA 
reductase activity in hypercholeaterolemic rats. However, 
further studies are required to gain more insight in revealing 
out the precise mechanisms underlying these effects. 
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